GB201012660D0 - Inhaler and formulation - Google Patents
Inhaler and formulationInfo
- Publication number
- GB201012660D0 GB201012660D0 GBGB1012660.5A GB201012660A GB201012660D0 GB 201012660 D0 GB201012660 D0 GB 201012660D0 GB 201012660 A GB201012660 A GB 201012660A GB 201012660 D0 GB201012660 D0 GB 201012660D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- inhaler
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1012660.5A GB201012660D0 (en) | 2010-07-28 | 2010-07-28 | Inhaler and formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1012660.5A GB201012660D0 (en) | 2010-07-28 | 2010-07-28 | Inhaler and formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201012660D0 true GB201012660D0 (en) | 2010-09-15 |
Family
ID=42799224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1012660.5A Ceased GB201012660D0 (en) | 2010-07-28 | 2010-07-28 | Inhaler and formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201012660D0 (en) |
-
2010
- 2010-07-28 GB GBGB1012660.5A patent/GB201012660D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100032I1 (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
HK1187049A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
GB2484244B (en) | Anaesthetic formulation | |
EP2542086A4 (en) | Compounds and therapeutic uses thereof | |
RS55446B1 (en) | Inhalator | |
GB201010193D0 (en) | Medicinal use | |
ZA201208173B (en) | Peptices and their use | |
SI2605757T1 (en) | Nalbuphine-based formulations and uses thereof | |
IL221768A (en) | Inhalator | |
PT2521445T (en) | Formulation and use thereof | |
EP2608785A4 (en) | Lipomacrocycles and uses thereof | |
PT2563806E (en) | Human leukolectins and uses thereof | |
EP2529013A4 (en) | Novel -glucosidase and uses thereof | |
EP2615094A4 (en) | Sesterterpene compounds and use thereof | |
GB201012660D0 (en) | Inhaler and formulation | |
EP2657236A4 (en) | Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof | |
EP2638160A4 (en) | Nuclions and ribocapsids | |
GB201002451D0 (en) | Pharmaceutical comopitions and devices | |
GB201001383D0 (en) | New compounds and medical uses | |
GB201001376D0 (en) | New compounds and medical uses | |
GB201001370D0 (en) | New compounds and medical uses | |
GB201001364D0 (en) | New compounds and medical uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |